Synthetic aromatic compounds interfering with melanogenesis are responsible of the rising trend of malignant melanoma incidence

Medical Hypotheses

Volumn 76, Issue 3, 2011, Pages 374-377

  Morpurgo, Giorgio ^a   Babudri, Nora ^a   Fioretti, Bernard ^a   Franciolini, Fabio ^a   Catacuzzeno, Luigi ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; AROMATIC COMPOUND; BENZOIC ACID; CATECHOL OXIDASE; COSMETIC; DOPA; MELANIN; MONOPHENOL MONOOXYGENASE; POLYCHLORINATED BIPHENYL; RESORCINOL; SUNSCREEN; THIAMAZOLE;

ARTICLE; CELL PROTECTION; CREAM; DNA REPAIR; ENZYME ACTIVITY; HUMAN; INCIDENCE; MELANOCYTE; MELANOGENESIS; MELANOMA; MUTAGENICITY; NONHUMAN; ULTRAVIOLET RADIATION;

DNA REPAIR; HUMANS; MELANOCYTES; MELANOMA; MONOPHENOL MONOOXYGENASE; PHENOLS; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 79751536868     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2010.10.044     Document Type: Article

References (43)

1. Lens M.B., Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 2004, 150:179-185.
2. Whiteman D.C., Stickley M., Watt P., Hughes M.C., Davis M.B., Green A.C. Anatomic site, sun exposure, and risk of cutaneous melanoma. J Clin Oncol 2006, 24:3172-3177.
3. Slominski A., Zbytek B., Slominski R. Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells. Int J Cancer 2009, 124:1470-1477.
4. Gudbjartsson D.F., Sulem P., Stacey S.N., Goldstein A.M., Rafnar T., Sigurgeirsson B., et al. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat Genet 2008, 40:886-891.
5. Kadekaro A.L., Kavanagh R., Kanto H., Terzieva S., Hauser J., Kobayashi N., et al. Alpha-melanocortin and endothelin-1 activate antiapoptotic pathways and reduce DNA damage in human melanocytes. Cancer Res 2005, 65:4292-4299.
6. Bohm M., Wolff I., Scholzen T.E., Robinson S.J., Healy E., Luger T.A., et al. Alpha-melanocyte-stimulating hormone protects from ultraviolet radiation-induced apoptosis and DNA damage. J Biol Chem 2005, 280:5795-5802.
7. Hauser J.E., Kadekaro A.L., Kavanagh R.J., Wakamatsu K., Terzieva S., Schwemberger S., et al. Melanin content and MC1R function independently affect UVR-induced DNA damage in cultured human melanocytes. Pigment Cell Res 2006 Aug, 19(4):303-314.
8. Sebhat I.K., Martin W.J., Ye Z., Barakat K., Mosley R.T., Johnston D.B., et al. Design and pharmacology of N-[(3R)-1, 2, 3, 4-tetrahydroisoquinolinium-3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)-2-[4-cyclohexyl-4-(1H-1,2,4-triazol-1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonist. J Med Chem 2002, 45:4589-4593.
9. Wikberg J.E.S. Melanocortin receptors: new opportunities in drug discovery. Expert Opin Ther Patents 2001, 11:61-76.
10. Slominski A., Jastreboff P., Pawelek J. l-Tyrosine stimulates induction of tyrosinase activity by MSH and reduces cooperative interactions between MSH receptors in hamster melanoma cells. Biosci Rep 1989, 9:579-586.
11. McLane J., Osber M., Pawelek J.M. Phosphorylated isomers of L-DOPA stimulate MSH binding capacity and responsiveness to MSH in cultured melanoma cells. Biochem Biophys Res Commun 1987, 145:719-725.
12. Slominski A., Pawelek J. MSH binding in Bomirski amelanotic hamster melanoma cells is stimulated by l-tyrosine. Biosci Rep 1987, 7:949-954.
13. Mokdad A.H., Serdula M.K., Dietz W.H., Bowman B.A., Marks J.S., Koplan J.P. The spread of the obesity epidemic in the United States 1991-1998. JAMA 1999, 282:1519-1522.
14. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkemeier L.R., et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997, 88:131-141.
15. Australian regulatory guidelines for OTC medicines. 1 July 2003, Common Wealth Department of Health and Ageing. http://www.tga.health.gov.au.
16. Zhang J.P., Chen Q.X., Song K.K., Xie J.J. Inhibitory effects of salicylic acid family compounds on the diphenolase activity of mushroom tyrosinase. Food Chem 2006, 95(4):579-584.
17. Brooks PC, Morais D, Rodriguez D. Inhibition of melanogenesis and melanoma metastasis with p-aminobenzoic acid (PABA). United States Patent 7691905.
18. Sezginturk M.K., Goktug T., Dinckaya E. Detection of benzoic acid by an amperometric inhibitor biosensor based on mushroom tissue homogenate. Food Technol Biotechnol 2005, 43(4):329-334.
19. Espinoza Arranz J., Sanchez Hernandez J.J., Bravo Fernandez P., et al. Cutaneous malignant melanoma and sun exposure in Spain. Melanoma Res 1999, 9:199-205.
20. Holly E.A., Aston D.A., Cress R.D., et al. Cutaneous melanoma in women, I: exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light. Am J Epidemiol 1995, 141(10):923-933.
21. Westerdahl J., Olsson H., Masback A., et al. Is the use of sunscreens a risk factor for malignant melanoma?. Melanoma Res 1995, 5:59-65.
22. Wolf P., Quehenberger F., Mullegger R., et al. Phenotypic markers, sunlight-related factors and sunscreen use in patients with cutaneous melanoma: an Austrian case-control study. Melanoma Res 1998, 8:370-378.
23. Klepp O., Magnus K. Some environmental and bodily characteristics of melanoma patients. A case-control study. Int J Cancer 1979, 23:482-486.
24. Graham S., Marshall J., Haughey B., et al. An inquiry into the epidemiology of melanoma. Am J Epidemiol 1985, 122:606-619.
25. Holman C.D., Armstrong B.K., Heenan P.J. Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. J Natl Cancer Inst 1986, 76:403-414.
26. Osterlind K., Tucker M.A., Stone B.J., et al. The Danish case-control study of cutaneous malignant melanoma, II: the importance of UV-light exposure. Int J Cancer 1988, 42:319-324.
27. Beitner H., Norell S.E., Ringborg U., et al. Malignant melanoma: aetiological importance of individual pigmentation and sun exposure. Br J Dermatol 1990, 122:43-51.
28. Autier P., Dore J.F., Schifflers E., et al. Melanoma and use of sunscreens: an EORTC case-control study in Germany, Belgium and France. The EORTC melanoma cooperative group. Int J Cancer 1995, 61:749-755.
29. Huncharek M., Kupelnick B. Use of topical sunscreens and the risk of malignant melanoma: a meta-analysis of 9067 patients from 11 case-control studies. Am J Public Health 2002, 92(7):1173-1177.
30. Hanson K.M., Gratton E., Bardeen C.J. Sunscreen enhancement of UV-induced reactive oxygen species in the skin. Free Radic Biol Med 2006, 41:1205-1212.
31. van der Pols J.C., Williams G.M., Pandeya N., Logan V., Green A.C. Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. Cancer Epidemiol Biomarkers Prev 2006, 15:2546-2548.
32. Khatib S., Nerya O., Musa R., Tamir S., Peter T., Vaya J. Enhanced substituted resorcinol hydrophobicity augments tyrosinase inhibition potency. J Med Chem 2007, 50:2676-2681.
33. Yan Shi, Qing-Xi Chen, Qin Wang, Kang-Kang Song, Ling Qiu Inhibitory effects of cinnamic acid and its derivatives on the diphenolase activity of mushroom (Agaricus bisporus) tyrosinase. Food Chem 2005, 92:707-712.
34. Kong Y.H., Jo Y.O., Cho C.W., Son D., Park S., Rho J., et al. Inhibitory effects of cinnamic acid on melanin biosynthesis in skin. Biol Pharm Bull 2008, 31:946-948.
35. Vad N.M., Yount G., Moore D., Weidanz J., Moridani M.Y. Biochemical mechanism of acetaminophen (APAP) induced toxicity in melanoma cell lines. J Pharm Sci 2009, 98:1409-1425.
36. Kasraee B., Hügin A., Tran C., Sorg O., Saurat J.H. Methimazole is an inhibitor of melanin synthesis in cultured B16 melanocytes. J Invest Dermatol 2004, 122:1338-1341.
37. Matthew E., Laskin J.D., Zimmerman E.A., Weinstein I.B., Hsu K.C., Engelhardt D.L. Benzodiazepines have high-affinity binding sites and induce melanogenesis in B16/C3 melanoma cells. Proc Natl Acad Sci USA 1981, 78:3935-3939.
38. Fuller B.B., Drake M.A., Spaulding D.T., Chaudhry F. Downregulation of tyrosinase activity in human melanocyte cell cultures by yohimbine. J Invest Dermatol 2000, 114:268-276.
39. Van Woert M.H. Effect of phenothiazines on melanoma tyrosinase activity. J Pharmacol Exp Ther 1970, 173:256-264.
40. Fabbri D, Dettori MA, Ruzza P, Fadda A, Sanna D, Serra PA, et al. Preparation of antioxidant hydroxylated biphenyls as tyrosinase inhibitors. 5° Indo-Italian workshop on chemistry and biology of antioxidants. Rome 5-8 July 2009.
41. Sinks T., Steele G., Smith A.B., Watkins K., Shults R.A. Mortality among workers exposed to polychlorinated biphenyls. Am J Epidemiol 1992, 136:389-398.
42. Loomis D., Browning S.R., Schenck A.P., Gregory E., Savitz D.A. Cancer mortality among electric utility workers exposed to polychlorinated biphenyls. Occup Environ Med 1997, 54:720-728.
43. Bahn A.K., Rosenwaike I., Herrmann N., Grover P., Stellman J., O'Leary K. "Melanoma after exposure to PCBs." Letter. N Engl J Med 1976, 295:450.